⚕ GalenOps CRO console
← 709 (USA)

709-1238

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 709 (USA) (Dr. Novak) · consented 2013-05-15
Adverse events
8
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

moderate assessed 2026-08-18

Moderate APPLICATION SITE DERMATITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-30 (study day 16.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate APPLICATION SITE DISCHARGE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-30 (study day 16.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-30 (study day 16.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate COUGH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-09 (study day 26.0); relationship: NONE

moderate assessed 2026-08-18

Moderate DIARRHOEA — outcome: RECOVERED/RESOLVED; onset 2013-05-28 (study day 14.0); relationship: NONE

moderate assessed 2026-08-18

Moderate HIP FRACTURE — outcome: RECOVERED/RESOLVED; onset 2013-05-31 (study day 17.0); relationship: NONE

mild assessed 2026-08-18

Mild SKIN LESION EXCISION — outcome: RECOVERED/RESOLVED; onset 2013-06-28 (study day 45.0); relationship: NONE

moderate assessed 2026-08-18

Moderate UPPER RESPIRATORY TRACT INFECTION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-09 (study day 26.0); relationship: NONE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.